ARCHIVES

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

This article is from The Cancer Letter archive.

Vol. 13 No. 19 | May 8, 1987

Download PDF Visit The Full Archive

Related Articles

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

June Panel Meeting Dropped

June 3, 1977

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011